CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis

Lung Cancer

Volumn 59, Issue 2, 2008, Pages 155-163

  Shi, Xiuquan ^a   Zhou, Suhua ^a   Wang, Zhongxu ^b   Zhou, Zongcan ^c   Wang, Zengzhen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Health Science Center   (China)

Author keywords

CYP1A1; GSTM1; Lung cancer; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1A1; ENVIRONMENTAL CHEMICAL; GLUTATHIONE TRANSFERASE M1; ISOLEUCINE; VALINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CYP1A1 GENE; EXON; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; HUMAN; LUNG CANCER; POPULATION GENETICS; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 CYP1A1; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 38649097512     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.004     Document Type: Article

References (53)

1. Neumann A.S., Sturgis E.M., and Wei Q.Y. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42 (2005) 65-92
2. Kriek E., Van Schooten F.J., Hillebrand M.J., Van Leeuwen F.E., Den Engelse L., De Looff A.J., et al. DNA adducts as a measure of lung cancer risk in humans exposed to polycyclic aromatic hydrocarbons. Environ Health Perspect 99 (1993) 71-75
3. Li W.Y., Lai B.T., and Zhan X.P. The relationship between genetic polymorphism of metabolizing enzymes and the susceptibility to lung cancer [in Chinese]. Chin J Epidemiol 25 (2004) 1042-1045
4. Vineis P., and Husgafvel-Pursiainen K. Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26 (2005) 1846-1855
5. Mohr L.C., Rodgers J.K., and Silvestri G.A. Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Res 23 (2003) 2111-2124
6. Raimondi S., Paracchini V., Autrup H., Barros-Dios J.M., Benhamou S., Boffetta P., et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164 (2006) 1027-1042
7. Reszka E., and Wasowicz W. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk. Int J Occup Med Environ Health 14 (2001) 99-113
8. Mathijssen R.H., and Van Schaik R.H. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment. Eur J Cancer 42 (2006) 141-148
9. Seow A.L., Ng D.P., Tan K.W., and Zhao B. CYP1A1 polymorphism, environmental exposures and lung cancer risk among non-smoking Chinese women in Singapore. AACR Meeting Abstracts (2004) 1221
10. Marchand L.L., Guo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 (2003) 339-346
11. Houlston R.S. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10 (2000) 105-114
12. Ye Z., Song H.L., Higgins J.P., Pharoah P., and Danesh J. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3 (2006) e91
13. Vineis P., Veglia F., Benhamou S., Butkiewicz D., Cascorbi I., Clapper M.L., et al. CYP1A1 T3801C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104 (2003) 650-657
14. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
15. Hu Z.B., Ma H.X., Chen F., Wei Q.Y., and Shen H.B. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14 (2005) 1810-1818
16. Hu Y.L., Gao Y., and Zhang Q. Genetic polymorphisms of CYP1A1, 2D6 and GSTM1 related with susceptibility to lung cancer [in Chinese]. Tumor 18 (1998) 269-271
17. Song N., Tan W., Tang H.J., and Lin D.G. Impact of cytochrome P450 gene mutations on the risk of development of lung cancer in a Chinese population [in Chinese]. Chin J Cancer 18 (1999) 495-498
18. Song N., Tan W., Xing D.Y., and Lin D.G. CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22 (2001) 11-16
19. Yin L., Pu Y., Liu T.Y., Tung Y.H., Chen K.W., and Lin P. Genetic polymorphisms of NAD(P)H quinine oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 33 (2001) 133-141
20. Zhou X.W., Shi Y., and Zhou Y.K. The relationship between CYP1A1 genetic polymorphism and susceptibility to lung cancer [in Chinese]. J Environ Occup Med 19 355-7 (2002) 87
21. Wang J.W., Deng Y.F., Li L., Kuriki K., Ding J., Pan X., et al. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci 94 (2003) 448-452
22. Cai X.L., Chen S.D., Wang B.G., Chen M.X., and Xian X.Z. Genetic polymorphisms of CYP1A1 MspI susceptibility of lung cancer of Guangdong population [in Chinese]. Jiangsu J Prev Med 14 (2003) 1-2
23. GuYF, Zhang S.C., Lai B.T., Wang H., and Zhan X.P. Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility [in Chinese]. Chin J Lung Cancer 7 (2004) 112-117
24. Liang G.Y., Pu Y.P., and Yin L.H. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China [in Chinese]. Hereditas (Beijing) 26 (2004) 584-588
25. Dong C.T., Yang Q., Jiang B., and Dong Q.N. Study on the relationship between polymorphisms of CYP1A1 gene and susceptibility of lung cancer in Sichuan population [in Chinese]. Chin J Lung Cancer 7 (2004) 38-42
26. Chen S.D., Ye W.Y., and Chen Q. Relationship between CYP1A1 polymorphism, serum selenium and lung cancer [in Chinese]. Chin J Public Health 20 (2004) 796-797
27. Li Y., Tang X.Y., and Ma X.T. Cytochrome P24501A1 polymorphisms and susceptibility to lung cancer: a case-control study on Chinese population in Henan [in Chinese]. Henan Med Res 14 (2005) 227-229
28. Wang D.Q., Chen S.D., Wang B.G., Cai X.L., and Xian X.Z. A case control study on relationship between lung cancer and genetic polymorphism of CYP1A1, CYP2E1 and GSTM1 in Han nationality, in Guangzhou area [in Chinese]. Bulletin Chin Cancer 15 (2006) 579-582
29. Qian B.Y., Han H.W., Gu F., He M., Li H.X., Song F.J., et al. Case-control study genetic polymorphism in CYP1A1 and GSTM1 and smoking and susceptibility to lung cancer [in Chinese]. Chin J Clin Oncol 33 (2006) 500-502
30. Hu Y.L., and Zhang Q. Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer [in Chinese]. Chin J Med Gene 16 (1999) 26-28
31. Chen S.Q., Xu L., Ma G.J., Wu J.Z., and Xue K.X. Identification of genetic polymorphism of CYP1A1 and GSTM1 and lung cancer patients by using allele-specific PCR and multiplex differential PCR [in Chinese]. Carcinog Teratog Mutag 11 (1999) 119-121
32. Xue K.X., Xu L., Chen S.Q., Ma G.J., and Chen J.Z. The relationship between polymorphisms of the CYP1A1 and GSTM1 genes and the susceptibility to lung carcinoma in Chinese population [in Chinese]. Carcinog Teratog Mutag 11 (1999) 326
33. London S.J., Yuan J.M., Coetzee G.A., Gao Y.T., Ross R.K., and Yu M.C. CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 9 (2000) 987-991
34. Zhang L.Z., Wang X., and Shi Y.X. Susceptibility to lung cancer is associated with genetic polymorphism of cytochrome P450 (CYP1A1) [in Chinese]. Acta Acad Med Xuzhou 21 (2001) 8-10
35. Xue K.X., Xu L., Chen S.Q., Ma G.J., and Wu J.Z. Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population [in Chinese]. Chin J Med Gene 18 (2001) 125-127
36. Zhang L.Z., Wang X., Hao X.Z., Shi Y.X., and Liu Z.H. Relationship between susceptibility to lung cancer and genetic polymorphism in CYP1A1, GSTM1 [in Chinese]. Chin J Clin Oncol 29 (2002) 536-540
37. Yang X.R., Wacholder S., Xu Z., Dean M., Clark V., Gold B., et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett 214 (2004) 197-204
38. Gao J.R., Ren C.L., and Zhang Q. CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility [in Chinese]. Chin J Oncol 20 (1998) 185-186
39. Lan Q., He X.Z., Costa D.J., Tian L., Rothman N., Hu G., et al. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev 9 (2000) 605-608
40. Chen S., Xue K., Xu L., Ma G., and Wu J. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res 458 (2001) 41-47
41. Chan Y., Wang X., Wang X.Y., and Liang Z.Q. A study of genetic polymorphism of GSTM1 gene in normal population and lung cancer population in Yunnan [in Chinese]. Acta Yunnan Normal Univ 22 (2002) 52-54
42. Chan-Yeung M., Tan-Un K.C., Ip M.S., Tsang K.W., Ho S.P., Ho J.C., et al. Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 45 (2004) 155-160
43. Luo C.L., Chen Q., Cao W.F., and Chen S.D. Combined analysis of polymorphism of GSTM1 and mutagens and p53 gene in the patients with lung cancer [in Chinese]. Chin J Clin Oncol 31 (2004) 1218-1220
44. Wang N., Zhuang D.G., and Wu Y.M. Research on relationship between GSTM1 gene deletion and lung cancer genetic susceptibility [in Chinese]. Acta Henan Univ Sci Technol (Med Vol) 23 (2005) 7-8
45. Zeng M., Chen S.D., Xie C.M., Wang B.G., Feng Y.X., Chen M.X., et al. Case control study on relationship between lung cancer and its susceptibility marker [in Chinese]. Chin J Public Health 21 (2005) 771-774
46. Ye W.Y., Chen S.D., and Chen Q. Interaction between serum selenium level and polymorphism of GSTM1 in lung cancer [in Chinese]. Acta Nutrimenta Sinica 27 (2005) 17-20
47. Li D.R., Zhou Q.H., Yuan T.Z., Guo Z.L., Zhu W., Wang Y.P., et al. Study on the association between genetic polymorphism of CYP2E1, GSTM1 and susceptibility of lung cancer [in Chinese]. Chin J Lung Cancer 8 (2005) 14-19
48. Li Y., Tang X.Y., Ma X.T., and Chen J. Glutathione S-transferase M1 polymorphisms and susceptibility to lung cancer [in Chinese]. J Med Drug Forum 26 (2005) 10-12
49. Wang Q.M., Lu Q.F., Zen H.N., Bao M., and Zhang H.J. The relationship between CYP2C9 and GSTM1 genetic polymorphism and lung cancer susceptibility [in Chinese]. Cancer Res Prev Treat 33 (2006) 8-10
50. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., and Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9 (2000) 3-28
51. Perera F.P., Mooney L.A., Stampfer M., Phillips D.H., Bell D.A., Rundle A., et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective physicians' health cohort study. Carcinogenesis 23 (2002) 1641-1646
52. Houlston R.S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 8 (1999) 675-682
53. Nebert D.W., Petersen D.D., and Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1 (1991) 68-78